A Randomised, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Orally Administered DS102 in Patients With Acute Decompensated Alcoholic Hepatitis.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs DS 102 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 26 Feb 2018 Status changed from planning to not yet recruiting.
- 01 Aug 2017 New trial record